Drug-resistant tuberculosis: pediatric guidelines
- PMID: 21297522
- DOI: 10.1097/INF.0b013e31820b583d
Drug-resistant tuberculosis: pediatric guidelines
Abstract
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
